Independent
clinical laboratory industry has experienced less than 20 years' development in
China, but there were more than 110 independent clinical laboratories in China
with rapid development.
Kingmed,
Adicon and Dian placed on the top three respectively among large-scale
chain-store clinical laboratories. Market scale was approximately CNY 2.5
billion in 2012, only accounting for about 1.5% of market shares in clinical
laboratory industry currently.
But in
America, independent clinical laboratory industry accounted for one third of
market shares, so there is still a big gap when compared with America. Huidian
Research takes a view that sales value of Kingmed firstly broke through CNY 1
billion as of 2012, which can be deemed as China independent clinical
laboratory industry entered rapid-growth period.
Read
Complete Report with TOC @ http://www.radiantinsights.com/research/research-and-development-trend-of-china-independent-clinical-laboratory-market-2013-2017
Under the
background of new medical reform, independent clinical laboratory industry will
further expand so as to enter rapid-growth period. During this period,
increasing new entrants will step into this industry, chain enterprises and
solo independent laboratory will coexist.
But in the
long run, chain enterprises are equipped with the capacities of large-scale
purchase and standard management and administration for reducing production
costs; service network layout will obtain brand effect for attracting
customers.
However,
the service of solo independent laboratory is limited within 400 kilometers,
customer resources are inclined to be saturated. In addition, it will drop out
the market along with losses because of declined prices. Thus chain enterprises
are expected to be still prosperous.
Through
comparing testing project reserves, layout of service network station and
management and administration capability in domestic chain enterprises, Huidian
Research holds a view of Kingmed owns absolute competitive advantages and will
keep its leading position in industry due to high-end project reserves and many
laboratories are widely distributed; Adicon and Dian placed on the second,
Adicon has high-end project reserves and strict quality control standards,
while Dian owns differentiation competitive advantages such as level-to-level
administration laboratories, increase output and " agency + service "
mode for reducing purchasing costs etc.; DAAN Gene started late (2007), so it
is slightly inferior to the other three enterprises.
"Research
and Development Trend of China Independent Clinical Laboratory Market,
2013-2017" mainly conducts an in-depth market research on development
environment and market status quo of China independent clinical laboratory
industry, makes an analysis of domestic market status quo, supply and demand,
upstream and downstream industries and business performance of key enterprises,
meanwhile makes a forecast for the industry so as to provide a decision-making
reference for enterprises to understand and invest such industry.
About Us
Radiant Insights is a platform for companies looking to meet their
market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
No comments:
Post a Comment